Nicotine Transdermal System
NDC Package 68016-290-88
Package Information
Nicotine Transdermal System is if you are under 18 years of age, ask a doctor before use before using this product, read the enclosed self-help guide for complete directions and other informationbegin using the patch on your quit dayif you smoke more than 10 cigarettes per day, use the following schedule below:Weeks 1 thru 2Weeks 5 and 6Weeks 7 and 8Step 1Step 2Step 3Use one 21 mg patch/dayUse one 14 mg patch/dayUse one 7 mg patch/dayif you smoke 10 or less cigarettes per day, start with Step 2 for 6 weeks, then Step 3 for 2 weeksapply one new patch every 24 hours on skin that is dry, clean and hairlessremove backing from patch and immediately press onto skin. Marketed by Chain Drug Consortium, Llc, this product is identified by NDC 68016-290 and is authorized under FDA application ANDA074612.
Identification & Billing
- RxCUI: 198029 - nicotine 14 MG/Day 24HR Transdermal System
- RxCUI: 198029 - 24 HR nicotine 0.583 MG/HR Transdermal System
- RxCUI: 198029 - nicotine 0.583 MG/HR 24HR Transdermal Patch
- RxCUI: 198029 - nicotine 14 MG per 24HR 1 Day Transdermal Patch
- RxCUI: 198030 - nicotine 21 MG/Day 24HR Transdermal System
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68016 - Chain Drug Consortium, Llc
- 68016-290 - Nicotine Transdermal System
- 68016-290-88 - 14 POUCH in 1 CARTON / 1 PATCH in 1 POUCH / 24 h in 1 PATCH
- 68016-290 - Nicotine Transdermal System
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68016-290-88 identifies a specific commercial package of 14 pouch in 1 carton / 1 patch in 1 pouch / 24 h in 1 patch of Nicotine Transdermal System Step 3, labeled by Chain Drug Consortium, Llc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Chain Drug Consortium, Llc on October 20, 1997. The current certification is valid through December 31, 2025.
How is this Chain Drug Consortium, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68016029088. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.